U.S. markets close in 3 hours 2 minutes

CVS Health Corporation (CVS.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
47.76-0.51 (-1.06%)
As of 4:40PM CET. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in EUR

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/29/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
62.85B75.50B70.20B86.35B75.00B
Enterprise Value 3
126.16B146.28B143.59B159.69B151.22B
Trailing P/E
9.0811.6311.5322.0817.78
Forward P/E 1
7.549.058.2010.348.71
PEG Ratio (5 yr expected) 1
0.951.120.992.161.29
Price/Sales (ttm)
0.280.320.300.380.33
Price/Book (mrq)
1.101.291.201.541.34
Enterprise Value/Revenue 3
0.482.252.162.362.34
Enterprise Value/EBITDA 6
6.8025.1031.2338.3538.07

Trading Information

Stock Price History

Beta (5Y Monthly) 0.65
52-Week Change 3-19.19%
S&P500 52-Week Change 37.93%
52 Week High 369.24
52 Week Low 347.38
50-Day Moving Average 349.75
200-Day Moving Average 354.50

Share Statistics

Avg Vol (3 month) 3260
Avg Vol (10 day) 3855
Shares Outstanding 51.31B
Float 1.31B
% Held by Insiders 10.19%
% Held by Institutions 179.64%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 41.69
Forward Annual Dividend Yield 43.51%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 34.14%
5 Year Average Dividend Yield 42.58
Payout Ratio 431.80%
Dividend Date 3N/A
Ex-Dividend Date 4Oct 21, 2020
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2019
Most Recent Quarter (mrq)Jun 30, 2020

Profitability

Profit Margin 3.14%
Operating Margin (ttm)5.28%

Management Effectiveness

Return on Assets (ttm)3.82%
Return on Equity (ttm)12.73%

Income Statement

Revenue (ttm)262.98B
Revenue Per Share (ttm)201.52
Quarterly Revenue Growth (yoy)3.20%
Gross Profit (ttm)44.52B
EBITDA 18.26B
Net Income Avi to Common (ttm)8.26B
Diluted EPS (ttm)6.29
Quarterly Earnings Growth (yoy)53.70%

Balance Sheet

Total Cash (mrq)17.46B
Total Cash Per Share (mrq)13.35
Total Debt (mrq)92.05B
Total Debt/Equity (mrq)134.67
Current Ratio (mrq)0.98
Book Value Per Share (mrq)52.04

Cash Flow Statement

Operating Cash Flow (ttm)15.99B
Levered Free Cash Flow (ttm)13.07B